CEO Michael Farrell reported 10% global revenue growth, driven by demand across the sleep health, breathing health, and residential care software portfolios. Device sales, including AirSense 10 and ...

ResMed's 10.2% revenue jump in Q2 was driven by strong demand for sleep health products, with a particular focus on expansion in digital health platforms. The 29.3% year-over-year bump up in ...

Piper Sandler analyst Adam Maeder raised the firm’s price target on ResMed (RMD) to $260 from $252 and keeps a Neutral rating on the shares.

ResMed beat Wall Street estimates for second-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea, a common sleep disorder.

Stifel analysts maintained a Hold rating on ResMed stock (NYSE:RMD) with a consistent price target of $250.00. The decision comes after reviewing the company's financial performance for the second ...

The company's revenue for the period rose 10.3% to $1.282 billion from $1.162 billion last year. Resmed Inc earnings at a glance (GAAP) : -Earnings: $344.6 Mln. vs. $208.6 Mln. last year.

Mr Trump has pledged to impose 25 per cent tariffs on imports from Mexico and Canada and 10 per cent on Chinese goods from Saturday. This means some of ResMed’s competitors that manufacture ...

ResMed stock tumbled Friday after organic sales growth slowed somewhat in the second fiscal quarter. But one analyst was upbeat.

For those who live with chronic neck pain, finding a supportive pillow is essential: The right one alleviates muscle tension and promotes proper alignment, leading to more comfortable nights (and ...

Throw Pillow Inserts - The pack of superior quality pillows is expertly woven and sewn to perfection. Vacuum Packaging - Our pillow inserts are compressed packed due to shipping purpose ...